A5064004087- Venous Thromboembolism Diagnosis and Management
- COVID-19 Clinical Research Studies
- COVID-19 and healthcare impacts
- Lymphoma Diagnosis and Treatment
- CAR-T cell therapy research
- Hemoglobinopathies and Related Disorders
- Blood disorders and treatments
- Blood groups and transfusion
- Cardiovascular Disease and Adiposity
- Viral-associated cancers and disorders
- Blood properties and coagulation
- Iron Metabolism and Disorders
- Respiratory viral infections research
- Chronic Lymphocytic Leukemia Research
- Dermatological and COVID-19 studies
- Pregnancy and preeclampsia studies
- Gestational Diabetes Research and Management
- Heparin-Induced Thrombocytopenia and Thrombosis
- Influenza Virus Research Studies
- Systemic Lupus Erythematosus Research
- Immune Response and Inflammation
- Proteoglycans and glycosaminoglycans research
University of Southern California
2021-2024
Thammasat University
2019-2024
University of North Carolina Health Care
2021
University of North Carolina at Chapel Hill
2019
Royal Forest Department
2013
Chulalongkorn University
2009
Recent studies have demonstrated a much higher incidence of venous thromboembolism (VTE) among Asian patients compared with previous studies. This study aims to determine dietary and behavioral factors that may contributed this increase. A case-control was conducted. Cases were objectively confirmed VTE between 2006 2009 at King Chulalongkorn Memorial Hospital. Patients underlying cancer, antiphospholipid syndrome arterial thrombosis excluded. Controls age sex-matched healthy volunteers....
Abstract Background MYC/BCL2 double expression (DE) is associated with poor prognosis in patients diffuse large B-cell lymphoma (DLBCL) receiving rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP). This study aimed to determine whether the addition of DE National Comprehensive Cancer Network Internal Prognostic Index (NCCN-IPI) could improve prediction disease progression DLBCL treated R-CHOP. Methods confirmatory prognostic factor retrospectively recruited...
Background Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma. The standard first-line therapy for DLBCL consists of rituximab cyclophosphamide doxorubicin vincristine and prednisone (R-CHOP). About 50–70% patients may be cured by R-CHOP. There was no data on external validation comparison international prognostic index, revised-IPI (R-IPI), enhanced-IPI (NCCN-IPI) to predict treatment outcomes in middle-income country with a resourced-limited setting.Objectives We...
To describe the characteristics of patients with antiphospholipid syndrome (APS) in an Asian clinical practice setting.We conducted a single-center, retrospective study APS attending rheumatology or hematology clinics, between January 2012 and December 2016.There were 450 suspected having referred to our clinics. Seventy-four (16.4%) diagnosed APS, 51% which definite. Fifty-two (70%) classified as primary 50% definite APS. The most common manifestation was stroke (33%), followed by deep vein...
<ns4:p>Background COVID-19 pandemics increases venous thromboembolism (VTE) risk during hospitalization, despite prophylactic anticoagulation. Limited radiological diagnosis in pandemic requires a guided protocol for anticoagulant adjustment. Methods This retrospective cohort study was conducted at single center as part of quality improvement program evaluating the efficacy and safety anticoagulation protocols. The focused on implementing guideline dosing based dynamic changes D-dimer levels...
<ns3:p>Background COVID-19 pandemics increases venous thromboembolism (VTE) risk during hospitalization, despite prophylactic anticoagulation. Limited radiological diagnosis in pandemic requires a guided protocol for anticoagulant adjustment. Methods This retrospective cohort study was conducted at single center as part of quality improvement program evaluating the efficacy and safety anticoagulation protocols. The focused on implementing guideline dosing based dynamic changes D-dimer levels...
<ns3:p>Background COVID-19 pandemics increases venous thromboembolism (VTE) risk during hospitalization, despite prophylactic anticoagulation. Limited radiological diagnosis in pandemic requires a guided protocol for anticoagulant adjustment. Methods This retrospective cohort study was conducted at single center as part of quality improvement program evaluating the efficacy and safety anticoagulation protocols. The focused on implementing guideline dosing based dynamic changes D-dimer levels...
This article has been withdrawn at the request of author(s). The Publisher apologizes for any inconvenience this may cause. full Elsevier Policy on Article Withdrawal can be found https://www.elsevier.com/about/our-business/policies/article-withdrawal.